Host-Parasite interaction: Selective pv-Fam-A family proteins of plasmodium vivax bind to a restricted number of human erythrocyte receptors

Journal of Infectious Diseases

Volumn 211, Issue 7, 2015, Pages 1111-1120

  Zeeshan, Mohammad ^a   Tyagi, Rupesh Kumar ^a   Tyagi, Kriti ^a   Alam, Mohd Shoeb ^a   Sharma, Yagya Dutta ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Host cell invasion.; Malaria parasite; receptor ligand interaction; Tryptophan rich proteins

Indexed keywords

CELL RECEPTOR; EPITOPE; ERYTHROCYTE RECEPTOR; PARASITE ANTIGEN; RECOMBINANT PLASMODIUM VIVAX TRYPTOPHAN RICH ANTIGEN; UNCLASSIFIED DRUG; PROTEIN BINDING; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY; RECOMBINANT PROTEIN; TRYPTOPHAN;

ANIMAL CELL; ANTIBODY AFFINITY; ARTICLE; BINDING AFFINITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FLOW CYTOMETRY; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; VACCINE PRODUCTION; AMINO ACID SEQUENCE; ANIMAL; BLOOD; CELL LINE; CRICETULUS; DNA SEQUENCE; FEMALE; GENETICS; GENOME; IMMUNOLOGY; METABOLISM; PARASITOLOGY; PLASMODIUM VIVAX MALARIA;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CELL LINE; CRICETULUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; FEMALE; GENOME, PROTOZOAN; HOST-PARASITE INTERACTIONS; HUMANS; MALARIA, VIVAX; PLASMODIUM VIVAX; PROTEIN BINDING; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, DNA; TRYPTOPHAN;

EID: 84928180878     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu558     Document Type: Article

References (43)

1. Cowman AF, Crabb BS. Invasion of red blood cells by malaria parasites. Cell 2006; 124:755-66.
2. Iyer J, Gruner AC, Renia L, Snounou G, Preiser PR. Invasion of host cells by malaria parasites: A tale of two protein families. Mol Microbiol 2007; 65:231-49.
3. Cheng Y, Wang Y, Ito D, et al. The Plasmodium vivax merozoite surface protein 1 paralog is a novel erythrocyte-binding ligand of P. vivax. Infect Immun 2013; 81:1585-95.
4. Gaur D, Mayer DC, Miller LH. Parasite ligand-host receptor interactions during invasion of erythrocytes by Plasmodium merozoites. Int J Parasitol 2004; 34:1413-29.
5. Kochar DK, Das A, Kochar SK, et al. Severe Plasmodium vivax malaria: A report on serial cases from Bikaner in northwestern India. Am J Trop Med Hyg 2009; 80:194-8.
6. Tanwar GS, Khatri PC, Chahar CK, et al. Thrombocytopenia in childhood malaria with special reference to P. vivax monoinfection: A study from Bikaner (Northwestern India). Platelets 2012; 23:211-6.
7. Kute VB, Goswami JG, Vanikar AV, et al. Unusual presentation of Plasmodium vivax: A neglected human malaria parasite. Parasitol Res 2012; 110:2573-6.
8. Kochar DK, Saxena V, Singh N, Kochar SK, Kumar SV, Das A. Plasmodium vivax malaria. Emerg Infect Dis 2005; 11:132-4.
9. Rodriguez-Morales AJ, Sanchez E, Vargas M, et al. Pregnancy outcomes associated with Plasmodium vivax malaria in northeastern Venezuela. Am J Trop Med Hyg 2006; 74:755-7.
10. Valecha N, Pinto RG, Turner GD, et al. Histopathology of fatal respiratory distress caused by Plasmodium vivax malaria. Am J Trop Med Hyg 2009; 81:758-62.
11. De las Salas B, Segura C, Pabon A, Lopes SC, Costa FT, Blair S. Adherence to human lung microvascular endothelial cells (HMVEC-L) of Plasmodium vivax isolates from Colombia. Malar J 2013; 12:347.
12. Chotivanich K, Udomsangpetch R, Suwanarusk R, et al. Plasmodium vivax adherence to placental glycosaminoglycans. PLoS One 2012; 7: e34509.
13. Singh H, Parakh A, Basu S, Rath B. Plasmodium vivax malaria: is it actually benign? J Infect Public Health 2011; 4:91-5.
14. Sharma YD. Knobs, knob proteins and cytoadherence in falciparum malaria. Int J Biochem 1991; 23:775-89.
15. Oh SS, Voigt S, Fisher D, et al. Plasmodium falciparum erythrocyte membrane protein 1 is anchored to the actin-spectrin junction and knob-Associated histidine-rich protein in the erythrocyte skeleton. Mol Biochem Parasitol 2000; 108:237-47.
16. Rug M, Prescott SW, Fernandez KM, Cooke BM, Cowman AF. The role of KAHRP domains in knob formation and cytoadherence of P. falciparum-infected human erythrocytes. Blood 2006; 108:370-8.
17. Carlton JM, Adams JH, Silva JC, et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 2008; 455:757-63.
18. Curtidor H, Ocampo M, Rodriguez LE, et al. Plasmodium falciparum TryThrA antigen synthetic peptides block in vitro merozoite invasion to erythrocytes. Biochem Biophys Res Commun 2006; 339:888-96.
19. Ntumngia FB, Bouyou-Akotet MK, Uhlemann AC, Mordmuller B, Kremsner PG, Kun JF. Characterisation of a tryptophan-rich Plasmodium falciparum antigen associated with merozoites. Mol Biochem Parasitol 2004; 137:349-53.
20. Bozdech Z, Mok S, Hu G, et al. The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites. Proc Natl Acad Sci U S A 2008; 105:16290-5.
21. Zeeshan M, Bora H, Sharma YD. Presence of memory T cells and naturally acquired antibodies in Plasmodium vivax malaria-exposed individuals against a group of tryptophan-rich antigens with conserved sequences. J Infect Dis 2013; 207:175-85.
22. Tyagi RK, Sharma YD. Erythrocyte binding activity displayed by a selective group of Plasmodium vivax tryptophan rich antigens is inhibited by patients' antibodies. PLoS One 2012; 7:e50754.
23. Garg S, Chauhan SS, Singh N, Sharma YD. Immunological responses to a 39.8 kDa Plasmodium vivax tryptophan-rich antigen (PvTRAg39.8) among humans. Microbes Infect 2008; 10:1097-105.
24. Alam MT, Bora H, Singh N, Sharma YD. High immunogenecity and erythrocyte-binding activity in the tryptophan-rich domain (TRD) of the 74-kDa Plasmodium vivax alanine-Tryptophan-rich antigen (PvATRAg74). Vaccine 2008; 26:3787-94.
25. Siddiqui AA, Singh N, Sharma YD. Expression and purification of a Plasmodium vivax antigen-PvTARAg55 tryptophan-And alaninerich antigen and its immunological responses in human subjects. Vaccine 2007; 26:96-107.
26. Siddiqui AA, Bora H, Singh N, Dash AP, Sharma YD. Expression, purification, and characterization of the immunological response to a 40-kilodalton Plasmodium vivax tryptophan-rich antigen. Infect Immun 2008; 76:2576-86.
27. Jalah R, Sarin R, Sud N, et al. Identification, expression, localization and serological characterization of a tryptophan-rich antigen from the human malaria parasite Plasmodium vivax. Mol Biochem Parasitol 2005; 142:158-69.
28. Mittra P, Singh N, Sharma YD. Plasmodium vivax: immunological properties of tryptophan-rich antigens PvTRAg 35.2 and PvTRAg 80.6. Microbes Infect 2010; 12:1019-26.
29. Chitnis CE, Miller LH. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J Exp Med 1994; 180:497-506.
30. Cohen GH, Wilcox WC, Sodora DL, Long D, Levin JZ, Eisenberg RJ. Expression of herpes simplex virus type 1 glycoprotein D deletion mutants in mammalian cells. J Virol 1988; 62:1932-40.
31. Sarin R, Sharma YD. Thioredoxin system in obligate anaerobe Desulfovibrio desulfuricans: Identification and characterization of a novel thioredoxin 2. Gene 2006; 376:107-15.
32. Cantor EM, Lombo TB, Cepeda A, et al. Plasmodium vivax: functional analysis of a highly conserved PvRBP-1 protein region. Mol Biochem Parasitol 2001; 117:229-34.
33. Koganei A, Tsuchiya T, Samura K, Nishikibe M. Use of whole sheep red blood cells in ELISA to assess immunosuppression in vivo. J Immunotoxicol 2007; 4:77-82.
34. Wickramarachchi T, Cabrera AL, Sinha D, et al. A novel Plasmodium falciparum erythrocyte binding protein associated with the merozoite surface, PfDBLMSP. Int J Parasitol 2009; 39:763-73.
35. Burns JM Jr, Adeeku EK, Dunn PD. Protective immunization with a novel membrane protein of Plasmodium yoelii-infected erythrocytes. Infect Immun 1999; 67:675-80.
36. Burns JM Jr, Dunn PD, Russo DM. Protective immunity against Plasmodium yoelii malaria induced by immunization with particulate blood-stage antigens. Infect Immun 1997; 65:3138-45.
37. Favaloro JM, Coppel RL, Corcoran LM, et al. Structure of the RESA gene of Plasmodium falciparum. Nucleic Acids Res 1986; 14:8265-77.
38. Foley M, Tilley L, Sawyer WH, Anders RF. The ring-infected erythrocyte surface antigen of Plasmodium falciparum associates with spectrin in the erythrocyte membrane. Mol Biochem Parasitol 1991; 46:137-47.
39. Kilejian A, Rashid MA, Aikawa M, Aji T, Yang YF. Selective association of a fragment of the knob protein with spectrin, actin and the red cell membrane. Mol Biochem Parasitol 1991; 44:175-81.
40. Leech JH, Barnwell JW, Aikawa M, Miller LH, Howard RJ. Plasmodium falciparum malaria: Association of knobs on the surface of infected erythrocytes with a histidine-rich protein and the erythrocyte skeleton. J Cell Biol 1984; 98:1256-64.
41. Pei X, Guo X, Coppel R, et al. The ring-infected erythrocyte surface antigen (RESA) of Plasmodium falciparum stabilizes spectrin tetramers and suppresses further invasion. Blood 2007; 110:1036-42.
42. Shi H, Liu Z, Li A, et al. Life cycle-dependent cytoskeletal modifications in Plasmodium falciparum infected erythrocytes. PLoS One 2013; 8: e61170.
43. Schulman S, Roth EF Jr, Cheng B, et al. Growth of Plasmodium falciparum in human erythrocytes containing abnormal membrane proteins. Proc Natl Acad Sci U S A 1990; 87:7339-43.